<DOC>
	<DOCNO>NCT01393782</DOCNO>
	<brief_summary>The investigator propose dose finding study determine feasibility Angiotensin II ( AII ) increase mean arterial pressure high-output shock . If AII show increase mean arterial pressure , could lead future pharmacologic development base AII hormonal pathway . The investigator propose 20 patient , randomize , placebo-controlled , blind study treatment high-output shock . Patients high-output shock cardiovascular SOFA ( sequential organ failure score ) score &gt; 4 eligible . In addition , patient must already receive cardiac output monitor cardiac index &gt; 2.4 L/min/ 1.73 m2 . Patients randomize intravenous AII saline blind fashion . There 10 patient arm . This safety dose find feasibility study . The investigator start small cohort consistent similar type study . The investigator estimate ten patient arm generate basis determine sufficient signal AII improve blood pressure dos outline . The primary endpoint study effect AII stand dose norepinephrine require maintain MAP 65 mmHg . Secondary endpoint effect AII urine output , serum lactate , creatinine clearance . 30 day post dose mortality also assess . Subjects discharge prior day 30 contact telephone assessment .</brief_summary>
	<brief_title>Intravenous AII Treatment Severe Hypotension High Output Shock : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<criteria>1 . Highoutput shock 2 . Cardiovascular SOFA score &gt; 4 3 . Cardiac Index &gt; 2.4 liters/min/BSA 1.73m2 4 . Indwelling arterial line already present part standard care 5 . Age &gt; 21 year age 6 . Signed consent form 7 . Use indwell urinary catheter standard care expect least 12 hour study intervention 1 . Patients acute coronary syndrome 2 . Patients known history vasospasm 3 . Patients history asthma 4 . Patients currently experience bronchospasm 5 . Patients active bleeding anticipate need &gt; 4 unit PRBC Hemoglobin &lt; 7g/dL condition would contraindicate draw serial blood sample</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>high output shock</keyword>
	<keyword>distributive shock</keyword>
	<keyword>warm shock</keyword>
	<keyword>septic shock</keyword>
	<keyword>pressor</keyword>
	<keyword>angiotensin</keyword>
	<keyword>ATII</keyword>
	<keyword>vasopressor</keyword>
</DOC>